Investigational anabolic therapies for osteoporosis. - Wikidata - awgldk - TriplyDB

Investigational anabolic therapies for osteoporosis.

Investigational anabolic therapies for osteoporosis.

http://www.wikidata.org/entity/Q37772520

about

Molecular Aspects of Bone Resorption in β-Thalassemia Major Dose-dependence of PTH-related peptide-1 on the osteogenic induction of MC3T3-E1 cells in vitro.Peripheral leptin regulates bone formation Nmp4/CIZ suppresses the parathyroid hormone anabolic window by restricting mesenchymal stem cell and osteoprogenitor frequency Nmp4/CIZ closes the parathyroid hormone anabolic window.Ulmus davidiana extract improves lumbar vertebral parameters in ovariectomized osteopenic rats.Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone.In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies.Appropriate models for novel osteoporosis drug discovery and future perspectives.Per-1 is a specific clock gene regulated by parathyroid hormone (PTH) signaling in osteoblasts and is functional for the transcriptional events induced by PTH.Acceleration of osteoblast differentiation by a novel osteogenic compound, DMP-PYT, through activation of both the BMP and Wnt pathways

P2860

Q26801066-573844D2-899E-4A06-A7BF-9350FBEFF2CB Q33627058-3CF22AAB-2636-4429-AFDF-4902FD873794 Q36481160-8071D4F8-A5E7-4584-A949-835D5CF85BB7 Q36547419-5CC74420-D9B0-4024-AA2C-D51794132508 Q36650555-1DC85ABD-9309-45F1-95C5-0CD43DB6B063 Q36841096-104A915A-BA25-4688-9EB2-AA788565CB0D Q37148287-9FA34CF9-C227-4C33-BC42-3713F3BB82A8 Q37947420-4DA1DBA3-9D7B-444F-9025-81439BA63888 Q38570326-4F94DC9B-AFA4-47FE-9080-A6CB20C379EF Q39602506-2970B519-57FF-41D5-B501-FE787098031B Q41436844-6CC8F174-3C60-4DC3-9F97-45DAB20A8313

P2860

Investigational anabolic therapies for osteoporosis.

http://www.wikidata.org/entity/Q37772520

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Investigational anabolic therapies for osteoporosis.

@en

Investigational anabolic therapies for osteoporosis.

@nl

type

label

Investigational anabolic therapies for osteoporosis.

@en

Investigational anabolic therapies for osteoporosis.

@nl

prefLabel

Investigational anabolic therapies for osteoporosis.

@en

Investigational anabolic therapies for osteoporosis.

@nl

P1433

Q37772520-AF564556-1A16-4BB2-A41A-FB91563DB4B8

P1476

Q37772520-B031328B-F5C5-4AA9-8AB2-2C4FF59821C0

P2093

Q37772520-0C785CE1-F52E-45C5-A73D-65AA78E07850

Q37772520-706BD9B5-62F0-49F7-99D7-A43D106B9219

Q37772520-CAC65302-109F-4FFA-93A7-FF4349AC68DD

P2860

Q37772520-010837F7-21A7-4FE4-87F0-1CD83731C287

Q37772520-027576B4-1D12-4756-803B-05C6962539D0

Q37772520-067E08EB-9224-42CE-8B92-49FEE09BC764

Q37772520-0CAA5BF2-3338-412D-991E-880A73D16E2B

Q37772520-0F1C1A1D-1FDC-4B4A-A4C9-D19950356E9B

Q37772520-0F295885-5C7C-4DF6-A3D0-C7CAA13480C6

Q37772520-0F4A02BF-AB59-4D79-9015-D09A6917575E

Q37772520-1051ECF3-37FD-4458-8345-2A3990A6430F

Q37772520-127FDAB6-9E31-4BBD-B034-0412FDC47E9D

Q37772520-1C474B4B-A156-457E-8EA6-4CB6846A743E

P304

Q37772520-E7F09760-DB68-4D35-BFE8-040DB29937F6

P31

Q37772520-3314E03A-DB96-4819-89AC-D24D9475FE4B

P356

Q37772520-DC00CC0E-31A3-4651-AFEB-4471130C6EE3

P407

Q37772520-4DF6E509-FB70-4CE8-B564-5898CC2B6DD2

P433

Q37772520-8056B60B-2A96-43E3-AA83-4D0280EF371F

P478

Q37772520-046ABCB6-E1B9-4752-AF75-C38637A3A303

P577

Q37772520-31DB7DF0-456E-4A28-93B0-98E1FE3D14CC

P698

Q37772520-320F0E84-DEE4-4931-9213-A6BD03B55359

P921

Q37772520-3528F8E9-4D70-4CD8-9D18-756785DEFF4A

P356

13543784.2010.501077

P1433

Expert Opinion on Investigational Drugs

P1476

Investigational anabolic therapies for osteoporosis.

@en

P2093

Naibedya Chattopadhyay

http://www.w3.org/2001/XMLSchema#string

Ravinder Goswami

http://www.w3.org/2001/XMLSchema#string

Ritu Trivedi

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of adipogenesis by Wnt signaling

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

Regulation of Wnt signaling during adipogenesis

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation

Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density

Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes

Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone

P304

995-1005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2010.501077

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20629616

http://www.w3.org/2001/XMLSchema#string

P921